A detailed history of Charles Schwab Investment Management Inc transactions in X Biotech Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 10,477 shares of XBIT stock, worth $53,851. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,477
Previous 10,477 -0.0%
Holding current value
$53,851
Previous $41,000 107.32%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$5.13 - $9.2 $175,528 - $314,787
-34,216 Reduced 76.56%
10,477 $59,000
Q1 2022

May 13, 2022

BUY
$8.64 - $11.71 $52,574 - $71,255
6,085 Added 15.76%
44,693 $387,000
Q3 2021

Nov 16, 2021

BUY
$12.95 - $18.24 $24,035 - $33,853
1,856 Added 5.05%
38,608 $500,000
Q1 2021

May 17, 2021

BUY
$15.92 - $20.3 $27,875 - $35,545
1,751 Added 5.0%
36,752 $632,000
Q3 2020

Nov 13, 2020

SELL
$13.97 - $21.16 $15,171 - $22,979
-1,086 Reduced 3.01%
35,001 $669,000
Q2 2020

Aug 14, 2020

BUY
$10.39 - $16.07 $30,899 - $47,792
2,974 Added 8.98%
36,087 $495,000
Q1 2020

May 15, 2020

SELL
$8.89 - $24.94 $158,490 - $444,630
-17,828 Reduced 35.0%
33,113 $352,000
Q4 2019

Feb 07, 2020

BUY
$8.33 - $19.95 $43,116 - $103,261
5,176 Added 11.31%
50,941 $951,000
Q3 2019

Nov 08, 2019

BUY
$6.86 - $10.46 $34,526 - $52,645
5,033 Added 12.36%
45,765 $479,000
Q2 2019

Aug 09, 2019

BUY
$6.99 - $11.27 $284,716 - $459,049
40,732 New
40,732 $309,000
Q3 2018

Nov 13, 2018

SELL
$2.31 - $4.69 $116,599 - $236,732
-50,476 Closed
0 $0
Q2 2018

Aug 08, 2018

SELL
$4.04 - $5.13 $152,037 - $193,057
-37,633 Reduced 42.71%
50,476 $227,000
Q1 2018

May 07, 2018

BUY
$3.92 - $5.35 $10,548 - $14,396
2,691 Added 3.15%
88,109 $472,000
Q4 2017

Jan 17, 2018

BUY
$3.9 - $4.66 $13,993 - $16,720
3,588 Added 4.38%
85,418 $337,000
Q3 2017

Nov 13, 2017

BUY
$4.14 - $5.12 $338,776 - $418,969
81,830
81,830 $358,000

Others Institutions Holding XBIT

About XBiotech Inc.


  • Ticker XBIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,439,300
  • Market Cap $156M
  • Description
  • XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...
More about XBIT
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.